Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Fenofibrate micronised 200 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
|
Fenofibrate micronised 67 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
|
Product containing precisely fenofibrate micronized 267 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
|
Product containing precisely fenofibrate micronized 160 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
|
Fenofibrate 67mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
|
Fenofibrate 134mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
|
Fenofibrate 200mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
|
Product containing precisely fenofibrate micronized 43 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
|
Fenofibrate micronised 87 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
|
Product containing precisely fenofibrate micronized 130 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
|
Product containing fenofibrate micronized |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
|
Product containing precisely fenofibrate micronized 134 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
|
Fenofibrate micronised 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
|
Fenofibrate micronised 200 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate micronised 200 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate micronised 67 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate micronised 67 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fenofibrate micronized 267 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fenofibrate micronized 267 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fenofibrate micronized 160 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fenofibrate micronized 160 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fenofibrate micronized 134 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fenofibrate micronized 134 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fenofibrate micronized 130 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fenofibrate micronized 130 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fenofibrate micronized 43 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fenofibrate micronized 43 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate micronised 87 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate micronised 87 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate micronised 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate micronised 50 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate 200mg gastro-resistant oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
|
Fenofibrate micronized 67mg gastro-resistant oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
|
Fenofibrate micronized 134mg gastro-resistant oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
|
Product containing precisely fenofibrate micronized 130 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fenofibrate micronized 43 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate micronised 87 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fenofibrate micronized 134 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate micronised 50 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate micronised 67 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
1 |
Fenofibrate micronised 200 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fenofibrate micronized 267 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fenofibrate micronized 160 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fenofibrate micronized 67 milligram and rosuvastatin (as rosuvastatin calcium) 5 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fenofibrate micronized 67 milligram and rosuvastatin (as rosuvastatin calcium) 5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fenofibrate micronized (substance) |
Inferred relationship |
Some |
1 |